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Polyamines  are  ubiquitous  active  biogenic  amines  which  contribute  to  basic  cellular  functions.  Hence,
their quantiﬁcation  in  samples  of  diverse  biological  origins  is  essential  for  understanding  how  they  func-
tion, especially  in disease-relevant  conditions.  We  present  here  a robust,  high-throughput  solid-phase
extraction  online  coupled  to  a liquid  chromatography–tandem  mass  spectrometry  (SPE–LC/MS/MS)
approach  for  the  simultaneous  quantiﬁcation  of  eight  polyamines  in  various  biological  samples.  The
polyamines  include  1,3-diaminopropane,  putrescine,  cadaverin,  N-acetyl-putrescine,  spermidine,  sperm-
ine,  N1-acetyl-spermine,  and  l-ornithine.  The  novelty  of  the  work  is  the  use  of two  SPE  columns  online
coupled  to  LC/MS/MS,  which  minimizes  the  sample  pretreatment  to a  single  derivatization  step.  Thenline solid phase extraction
andem mass spectrometry
olyamine
permidine
permine
analysis  is  complete  within  4  min,  making  the  method  highly  suitable  for  routine  clinical  analysis  and
high throughput  screenings.  The  method  was  fully  validated  with  serum  samples.  Dynamic  ranges  were
0.03 to 15  g/ml  for  ornithine  and  1  to  500  ng/ml  for  other  polyamines,  which  cover  physiological  con-
centrations  in  serum  samples.  Lower  limits  of quantiﬁcation  (LLoQ)  were  found  to be  between  0.1 and
5  ng/ml.  As  a proof  of  concept,  we  investigated  gender  differences  in  polyamine  levels  by  analyzing  the
serum levels  of  102  subjects.
 . Introduction
Polyamines are ubiquitous polycationic compounds associated
ith a variety of biological processes [1,2]. These active bio-
enic amines contribute to basic cellular functions, including cell
rowth, proliferation and differentiation, as well as regulating cel-
ular stress-response and survival mechanisms. Spermidine and
permine are two polyamines reported to have anti-inﬂammatory
s well as anti-oxidant activities [3], and have thus been impli-
ated in cellular and organismal stress defense during aging and
isease [4,5]. For instance, spermine was shown to provide pro-
ection from lethal sepsis in mice when applied intraperitoneally
6], and from paraquat-induced death in the fruit ﬂy Drosophila
elanogaster when added to ordinary food [7]. Indeed, spermi-
ine supplementation extends life span and reduces markers of
∗ Corresponding authors at: Joanneum Research, HEALTH–Elisabethstraße 5a,
raz, Austria. Tel.: +43 316 876 2113; fax: +43 316 876 2104.
E-mail address: ca.health@joanneum.at (C. Magnes).
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cell stress in various model organisms, including yeast, ﬂies, worms
and human immune cells [8], while polyamine-enriched food has
been shown to reduce mortality and prolong the health span of
aging mice [8,9]. The longevity-promoting effects of spermidine
in lower model organisms requires the induction of autophagy, a
degradation pathway that contributes to cellular self-renewal and
cell protection [8,10,11]. In fact, we recently revealed spermidine
to be a novel, conserved, and potent inducer of autophagy in model
organisms, in human cell cultures, and in vivo in various tissues
of mice [8,12]. On the other hand, polyamines can also be toxic to
cells at high levels, and can facilitate cell death, mainly by oxida-
tive mechanisms [13,14]. In this regard, polyamines are important
clinical biochemical markers for malignancy [15]. This was  ﬁrst
indicated in the urine of cancer patients, where polyamines were
present at higher levels than in healthy humans [15].
To understand the relevance of changes in polyamine proﬁles
detected in a given tissue, cell population or organism (obtained
Open access under CC BY-NC-ND license.from, for instance, patient samples or basic research models),
the biosynthetic activities of the polyamines, as well as their
catabolic pathways, need to be determined. Hence, metabolic pro-
ﬁling of polyamines and their close derivatives is prerequisite for
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nderstanding the potentially complex changes in polyamine con-
ent that can be induced by disease-relevant conditions. For such
etabolic proﬁling, an analytical method to accurately identify and
uantify a broader group of polyamines and their derivatives in
 single analysis would be most useful. Such an advance would
lso be signiﬁcant for the potential clinical use of polyamines as
iomarkers or pharmacological interventions.
The widespread interest in polyamines has led to the develop-
ent of several analytical methods for polyamine determination
2,16]. In general, analysis of polyamines obtained from various
iological samples is performed by chromatographic separation
rior to detection with selective detectors or mass spectrometers
17–23]. Hyphenated techniques, such as LC/MS, GC/MS or capillary
lectrophoreses coupled to MS  are among the most powerful meth-
ds for the analysis of metabolites [19–24]. Nonetheless, many
ublished analytical methods suffer from at least one of the follow-
ng drawbacks: they have long chromatographic run times; they
re optimized for determination of polyamines only in one spe-
iﬁc matrix; they have higher limits of detection; or they require
ime-consuming sample pretreatment steps [1,2,16,21,22,24–32].
Hence, there is a need for a more versatile technique that can be
sed across a range of matrices, so that levels in different tissues
r ﬂuids from a single person can be directly compared. Such com-
arisons between different tissue samples are important, because
olyamines are not evenly distributed throughout the human body.
or example, a number of polyamines have been shown to be raised
n the serum of breast cancer patients, even when the urine shows
ormal levels [21].
The present study was undertaken to develop a robust and
igh-throughput analytical method for the simultaneous determi-
ation of various polyamines, at levels ranging from trace amounts
o high concentrations. In particular, we aimed to design a uni-
ersal method for quantiﬁcation of polyamines in a broad range
f biological matrices. We  report here a novel analytical method
pplying two SPE columns on-line coupled to a highly sensitive
nd selective LC/MS/MS that allows the separation and unam-
iguous determination of eight polyamines in a broad variety of
iological samples. Using two SPE columns in parallel means that
ample preparation can be performed simultaneously with chro-
atographic separation and analyte detection, reducing the time
or a whole single analysis to just 4 min. Since SPE sample prepara-
ion was performed online, sample pre-treatment was signiﬁcantly
ccelerated by minimizing it to a single derivatization step before
easurement. No further extraction or manual clean-up was  nec-
ssary. The method is fully validated for human serum samples
nd could easily be extended to a higher number of polyamines if
equired.
. Materials and methods
.1. Chemicals
Biogenic amines, i.e. 1,3-diaminopropane (1,3-dap, ≥99%),
utrescine (put, ≥99%), cadaverine (cad, ≥99%), N-acetyl-
utrescine (N-actput, ≥98%), spermidine (spd, ≥98%), spermine
sp, ≥99%), N1-acetyl-spermine (N1-actsp, ≥97%), and l-ornithine
orn, ≥99%), along with four isotopically labeled internal stan-
ards d8-putrescine (d8-put, ≥99%), 13C5-ornithine (13C5-orn,
5%), d8-spermin (d8-sp, 95%), and 13C4-spermidine (13C4-spd,
95%), as well as acetonitrile and methanol (both HPLC gradient
rade), trichloroacetic acid (TCA, ≥99%), sodium carbonate (≥99%),
ydrochloric acid (fuming, 37%), acetic acid (99.8–100.5%), isobutyl
hloroformate (≥99%), and human serum from clotted human male
hole blood, sterile-ﬁltered (mycoplasma tested, virus tested),
ere purchased from Sigma-Aldrich (Vienna, Austria). Phosphater. A 1331 (2014) 44– 51 45
buffered saline (PBS buffer, pH 7.2–7.3) was purchased from
Apotheke LKH–Univ. Klinikum Graz, Austria. Ultra-pure water
puriﬁed by a Milli-Q Gradient system (resistivity >18 M  cm;
Millipore, Bedford, USA) was  used for all experiments.
2.2. Preparation of standard solutions
Stock solutions of sp, N-actput, N1-act, sp, orn, 1,3-dap, spd,
put, and internal standard d8-sp were prepared by dissolving the
appropriate amount in water/methanol (7:3, v/v) to yield a concen-
tration of 1 mg/ml  for sp, N-actput, N1-actsp, orn, 1,3-dap, 5 mg/ml
for spd, and 0.5 mg/ml  for put and d8-sp. Stock solutions of internal
standards (ISTD) d8-put, 13C5-orn, and 13C4-spd were prepared in
water/methanol (1:1, v/v) to achieve a concentration of 1 mg/ml. A
stock solution of cad was prepared by dissolving the appropriate
amount in water/acetonitrile (7:3, v/v) to give a concentration of
1 mg/ml. All stock solutions were stored at −80 ◦C.
The concentration of the calibration solution was generally var-
ied from 1 to 500 ng/ml in order to cover as broad a physiological
range as possible. Five non-zero calibration standards and one zero
sample were used for calibration in each batch. In serum sam-
ples, however, the concentration of orn is typically higher than
500 ng/ml, so calibration solutions for orn were 0.03 to 15 g/ml.
The calibration solutions for serum samples were prepared by dilut-
ing all stock solutions, except orn, with water/methanol (7:3, v/v)
to achieve an intermediate working concentration of 10 g/ml.
The stock solutions of orn and the working standard solutions
were further diluted with water (double-distilled) to the desired
concentration for the calibration solutions and three quality con-
trol (QC) samples. Five non-zero calibration solutions and one
zero calibration solution were used for calibration in each batch.
The QC samples were prepared from a different set of working
stock than the calibration solution. QC concentration levels for orn
were 0.5, 5, and 10 g/ml and for the other polyamines 5, 50, and
100 ng/ml. ISTD stock solution was also diluted with water (double-
distilled)/methanol (7:3, v/v) to achieve a working solution with
a concentration of 6 g/ml, and was further diluted with water
(double-distilled) to prepare an ISTD mix  solution with a concen-
tration of 200 ng/ml. The isotopically labeled d8-put was used as
internal standard for N-actput, 1,3-dap, cad and put to calculate
peak/area ratios. For sp and N1-actsp, d8-sp was  used as internal
standard. For Spd and orn, the internal standards 13C4-spd and
13C5-orn, respectively, were used.
2.3. Extraction and derivatization protocols
Polyamine extraction from biological sources is commonly per-
formed by acid extraction with cold TCA or perchloric acid (PCA)
with subsequent neutralization for analysis of cultured cells [33]
and animal and plant tissue [34]. In general, homogenization is
required for tissue, and a variety of standard techniques can be
used (for a set of references see [34]). For tissues that are difﬁcult
to homogenize (e.g. plant tissues or chitin-rich insects), a protocol
involving repeated freeze–thaw cycles may  be beneﬁcial, especially
when larger sample numbers need to be processed [34]. Based
on these methods [33,34], the following protocols were devel-
oped for the polyamine analyses described in this paper. Extraction
protocols for serum, tissue, cell and whole-blood samples are sum-
marized in Fig. 1. For tissue, cell or whole-blood samples, an
individual dilution step was  required before sample preparation,
which enabled polyamine concentrations to fall within the linear
calibration range. Table 1 shows the expected concentrations of
polyamines in various tissues, organism or cells. Based on this con-
centration range, samples were individually diluted by using the
dilution factor D speciﬁc for tissue, cell or whole blood. This dilu-
tion factor D was calculated for the analytes put, spd and sp. Sample
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lood  samples. 1Homogenization can be omitted if cultured cells in suspension or w
ilution was always performed by increasing the volume of TCA and
S. D is calculated for 30 mg  tissue or 107 cells or 20 l whole-blood
amples. For orn, no dilution was required, since the concentration
f orn in different samples was always within the calibration range
f orn.
able 1
xpected values of polyamines extracted from various tissues, organisms or cells. The tab
ynthetic complete medium, worms, ﬂies) or 6–10 young adult (3–5 month old) individua
95%  conﬁdence interval) of the polyamine content of indicated samples. For details of str
efers  to wet weight of tissues or whole organisms determined before polyamine extract
olyamine concentrations to fall within the linear calibration range (1–500 ng/ml). Theref
lood  samples. D was  calculated for 30 mg  tissue, 107 cells, or 20 l whole-blood sample
ince  a different calibration range was used (0.03–15 g/ml).
Source (strain) Expected range of polyamines
Putrescine Spermidine Spermine
Yeast (S. cerevisiae, BY4741) 2.2 (±0.5) 16 (±3) 8 (±7) 
Bacteria (E. coli, XL-1) 4.2 (±1.1) 3.6 (±0.9) 0.9 (±0.1
Worm (C. elegans, N2) 51 (±39) 126 (±86) n.a. 
Fruit  ﬂy heads (D. melanogaster, w1118) 2.2 (±2.7) 125 (±51) 16 (±8) 
Mouse liver tissue (M.  musculus, C57BL/6N) 1.1 (±0.8) 134 (±81) 176 (±10
Mouse heart tissue (M. musculus, C57BL/6N) 0.4 (±0.3) 12 (±8) 38 (±22) 
Mouse whole blood (M.  musculus, C57BL/6N) 0.1 (±0.1) 4.7 (±2.1) 0.6 (±0.4s and is listed in Table 3. D is calculated for 30 mg  tissue or 107 cells or 20 l whole
blood is used, but thoroughly vortexing to evenly mix  samples is recommended.
The derivatization of polyamines was carried out accord-
ing to the method of Byun et al. [21]. Amine carbamoylation
derivatization of polyamines was performed by using isobutyl
chloroformate. The derivatization protocol is presented in
Fig. 1.
le presents mean values from 6 to 9 biological replicates (cultured growing cells in
ls (mice) ±1.96 × standard deviation (SD), giving an estimate of the expected range
ains and conditions, see Section 2. n.a. data ‘not available’ (below LLoQ). Weight (g)
ion. In some cases, samples had to be diluted before sample preparation to enables
ore D indicates the speciﬁc dilution factor for put, spd and sp in tissue, cell or whole
s. Samples were diluted with TCA and IS. For orn, no sample dilution was required
Tissue/cell/blood speciﬁc dilution
factor D for put, spd, sp
 l-Ornithine Units2
15 (±3) (g/109 cells) 10
) 0.08 (±0.04) (g/OD600) 250
n.a. (g/g sample) 240
6.6 (±2) (g/g sample) 240
3) 34 (±34) (g/g sample) 330
2.9 (±5) (g/g sample) 100
) n.a. (g/ml sample) 10
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.4. Chromatographic methods
All experiments were carried out on an Ultimate 3000 HPLC
ystem comprising an autosampler and a 10-way switching valve
nit coupled to a triple-quadrupole mass spectrometer, a Quan-
um TSQ Ultra AM,  both from Thermo Fisher Scientiﬁc (San Jose,
A). The system was controlled by Xcalibur Software 2.1. The oven
f the autosampler was maintained at room temperature, and the
ray at 5 ◦C. For online SPE–LC/MS/MS, two Strata-X SPE cartridges
2 × 20 mm,  25 m particle size) from Phenomenex (California,
SA) were installed. Additionally, an in-line ﬁlter (KrudKatcher
lassic HPLC In-Line Filter, 0.5 m Depth Filter, Phenomenex
California, USA)) was placed in front of the 10-way switching valve
nit to protect both SPE columns.
Layout details of the online SPE–LC/MS/MS instrumentation,
uch as individual ﬂow rates, switching times and switching valve
ettings, are illustrated in Fig. 2. One ternary pump (pump 1) was
onnected to the autosampler and delivered solvents to one SPE col-
mn. The second ternary pump (pump 2) delivered solvents to the
econd SPE column and subsequently to the HPLC column. The HPLC
olumn comprised a reversed-phase C18 column (Kinetex reversed
hase C18; 50 × 2.1 mm i.d., 2.6 m particle size) from Phenomenex
California, USA). The outlet of the HPLC column was  connected
o the ion source of the mass spectrometer. If the HPLC switching
nit was set to valve position A, the sample was loaded onto SPE
 cartridge by using pump 1. In the meantime, the trapped ana-
ytes onto SPE 2 column (from previous loading step) were eluted
ith the solvent system of pump 2 and transferred onto the analyt-
cal column, where the analytes were further separated. For both
ycles (pump 1 and pump 2) the same solvent composition was
sed. Mobile phase A consisted of 0.2% acetic acid in water, while
obile phase B consisted of 0.2% acetic acid in acetonitrile. Detailed
ettings for both cycles 1 and 2, with the 10-way switching valve
nit, are shown for SPE 1 in Fig. 2.
.5. Mass spectrometry
A quantum TSQ Quantum triple quadrupole mass spectrometer
quipped with an electrospray ion source was used. The instrument
as operated in multiple reaction-monitoring mode (MRM). The
on source was operated in positive electrospray ionization (ESI)
ode. The MRM  of the precursor-product ion transitions, collision
nergies and tube lens offset are shown in detail in Supplementary
able 1S. The optimized conditions were: ESI spray voltage 4.0 kV,
heath gas pressure 20 AU, auxiliary gas pressure 15 AU, capillary
emperature 270 ◦C and skimmer offset −24 V. The scan was  per-
ormed in proﬁle mode with scan width (m/z) 0.1, scan time 0.05 s,
nd peak width of Q1 and Q3 0.7 (FWHM).
.6. Validation procedure
The analytical method was fully validated by evaluating speci-
city, linearity range, intra- and inter-day precision and accuracy,
ower limit of quantiﬁcation (LLoQ), limit of detection (LOD),
ecovery, and matrix effect. Particular attention was  paid to sam-
le stability, in that short-term stability, long-term stability, and
reeze–thaw cycles were evaluated. The method was applied to
erum samples.
. Results and discussionWe  have developed a method to separate eight polyamines
n a biological matrix in 4 min. Our online coupling of SPE with
C/MS/MS allowed us to minimize the sample preparation to a
ingle derivatization step. High sensitivity was maintained byr. A 1331 (2014) 44– 51 47
combining the derivatization of the polyamines with reversed-
phase separation.
3.1. Derivatization of polyamines
Analysis of trace amounts of polyamines requires a derivatiza-
tion step to enhance the sensitivity (see also discussion below, in
Section 3.2).
Our sample preparation procedure, including the derivatiza-
tion, builds on the method of Byun et al. [21], with signiﬁcant
modiﬁcations. Derivatization of polyamines was performed by
carbamoylation with isobutyl chloroformate, which is completed
within in 15 min  [21]. Moreover, carbamoyl derivates gave sharp
peaks upon measurement with LC/MS/MS. Compared to the
method of Byun et al., our sample preparation, with its single
derivatization step, resulted in a faster procedure, increased sensi-
tivity, and better detectability. No additional extractions or manual
clean-up steps were required. The initial liquid–liquid extraction
(and protein precipitation) step of Byun et al. [21] was omitted
because this led to a depletion of polyamines from the sample
(data not shown). Polyamines are known to bind to various macro-
molecules, which may  be the reason for the observed depletion
[35–37]. Since TCA is the most effective reagent for the extraction
of biogenic amines from various tissue samples, we also used it for
serum samples, and observed much higher recoveries than with
organic solvents (e.g. recovery of spermidine was 40% higher with
TCA than with acetonitrile, data not shown). After carbamoylat-
ing the polyamines with isobutyl chloroformate, the sample was
directly applied to the online SPE–LC/MS/MS. This avoided the need
for the additional liquid–liquid extraction of Byun et al., which also
required evaporation of the organic solvent and reconstitution of
the sample with an appropriate solvent mixture. In our method,
removal of the isobutyl chloroformate residue and other interfer-
ences before measurement was  fully automated with the online
SPE approach (described in detail in online SPE–LC/MS/MS). This
is of particular importance, since isobutyl chloroformate in posi-
tive ESI mode causes ion suppression effects that result in lower
speciﬁcity and sensitivity.
3.2. Chromatographic separation of polyamines
There are a number of reversed-phase LC/MS approaches for the
determination of polyamines that do not use a derivatization step
[19,20]; however those methods have their drawbacks.
Traditional reversed-phase separation of underivatized
polyamines is challenging because of the low retention of the
polyamines and their susceptibility to undergo severe tailing
[19,38]. Ion-pair reagents as additives in the LC separation enable
adequate retention time of polar analytes; however, these non-
volatile additives are known to cause ion-source contamination
and strong signal suppression in ESI–MS [20]. Thus, volatile
perﬂuorinated carboxylic acids, such as heptaﬂuorobutyric acid
or perﬂuoroheptanoic acid are more widely used as ion-pairing
reagents in LC/MS to improve peak shape and retention time
[20,30]. Unfortunately, due to their combined effect of ion-pairing
and surface-tension modiﬁcation, these additives also induce
signal suppression in ESI–MS [39,40]. The combination of hep-
taﬂuorobutyric acid with isopropanol/propionic acid helps to
increase polyamine signal in ESI, but signal suppression cannot be
completely prevented. Furthermore, heptaﬂuorobutyric acid has
an intensely unpleasant and rather persistent odor.
Hydrophilic-interaction liquid chromatography (HILIC) is a
valuable alternative to reversed-phase LC/MS for the analysis of
highly polar compounds such as polyamines [41,42]. With HILIC
columns, sufﬁcient retention can be achieved to move the more
polar analytes away from the solvent front [41,42]. In addition,
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Fig. 2. Connectivity sketch of the 10-port switching valve coupling the SPE and HPLC.
Cycle 1 (SPE 2): The sample was  loaded onto the SPE 2 column. The ﬂow rate of pump 1 was set to 1500 l/min. The six-way switching valve unit from the autosampler was
set  to loading position for 2.3 min  before sample injection. The binary gradient, starting with 90% B (ACN + 0.02% CH3COOH), was  held for 1.4 min before decreasing to 5% B
over  0.1 min  and holding for 4 min. For sample injection, the 6-port valve was  set to the analysis position after 2.3 min of the binary gradient. A sample volume of 250 l was
injected  and loaded onto the SPE 2, since the 10-port valve was set to loading position for SPE 2.
Cycle  2 (SPE 1): Trapped analytes on the SPE 1 column (from the previous loading step, when 10-port valve was switched to loading position for cycle 2) were eluted from the
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aolumn and further separated on the analytical column before detection. Chromat
ycle  1 since the 10-port valve for cycle 2 was set to analysis position. The ﬂow rate
ver  0.1 min, before decreasing over 0.4 min  back to 80% B, where it was  held for 3.
he highly volatile organic mobile phases used in HILIC increase
he sensitivity for ESI–MS [41]. We  used HILIC for the determina-
ion of polyamines in mice liver and ﬂy tissue with no additional
erivatization [8]. The HILIC approach is particularly suitable for
he determination of highly concentrated polyamines like intracel-
ular polyamines in tissue probes, but is not sufﬁciently sensitive
or measuring low concentrations of polyamines, such as in serum
amples.
.3. Online SPE–LC/MS/MS
For reproducible ionization efﬁciency, and to remove inter-
erences such as derivatization reagents from analytes, sample
re-treatment and separation by HPLC are crucial. By using a
etup consisting of two online SPE columns coupled to a C-18
nalytical column, we were able to omit the liquid–liquid extrac-
ion (Fig. 2). Solvent evaporation pre-treatment steps could also
e avoided because we injected a high sample volume (250 l).
fter derivatization, the sample was directly applied to the online
PE–LC/MS/MS.
Two Strata X columns were used as online SPE columns oper-
ting in parallel. Due to the polymeric nature and large particlehic separation and determination of analytes was performed simultaneously with
mp 2 was  set to 250 l/min. The binary gradient was  increased from 80% to 100% B
for isocratic separation of polyamines.
diameter (25 m)  of the packing material, these columns can
tolerate sample matrices that would block other column types.
Nonetheless, an in-line ﬁlter was installed at the start of the
SPE columns to prevent any possible column blockage (Fig. 2) to
enhance the lifetime of the SPE columns. Since sample prepara-
tion and LC/MS/MS measurement can be done in parallel (cycles 1
and 2) rather than sequentially, the measurement procedure can
be completed in half the time.
Brieﬂy, online SPE was  performed as follows (Fig. 2). We  describe
here the cycle for SPE 1 column. The cycles for the SPE 2 column
are the same as for SPE 1, but delayed:
3.3.1. Cycle 1 (SPE 1), loading
(i) Prior to sample injection, the SPE 1 column was ﬂushed
(pump 1) with mobile phase B (0.2% acetic acid in acetonitrile)
for 1.5 min. Since the ﬂow was  set to 1500 l/min, the wash-
ing period could be kept very short but was still sufﬁcient to
remove interferences from the SPE column prior to sample injec-
tion. Thus, the washing step increased the robustness of our system,
enabling us to apply our method to different biological matri-
ces. (ii) The SPE column was preconditioned in 0.8 min  due to
the high ﬂow rate. No shift in the retention time of the analytes
matogr. A 1331 (2014) 44– 51 49
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as observed. (iii) A high sample volume (250 l) was injected
fter 2.3 min  and transferred onto the SPE column. Despite the
igh ﬂow rate, the polyamine samples were retained on the SPE
olumn head, since the acetonitrile content (5%) was very low.
iv) The SPE column wash further ﬂushed with 5% acetonitrile
or 4 min  to remove any hydrophilic matrix material, including
sobutyl chloroformate, which could otherwise lead to ion suppres-
ion in positive electrospray ionization LC/MS/MS, if it co-elutes
ith the polyamines. (v) Elution of polyamines on the analytical
olumn used for chromatographic separation and MS determina-
ion was performed by switching the 10-way valve unit to position
.
.3.2. Cycle 2 (SPE 1), analyzing
(i) SPE 1 column was ﬂushed with increased acetonitrile
or 30 s to transfer the polyamines onto the analytical column,
here they were chromatographically separated. This high level
f organic solvent at the beginning is required to transfer the
olyamines from the SPE to the analytical column to avoid prior
eparation and peak broadening on the SPE column. (ii) The
olyamines are then separated by using 80% acetonitrile. The cur-
ent method efﬁciently separates eight polyamines as shown in
ig. 3, although baseline separation could not be achieved for
ll peaks due to the short run time (4 min). Generally, exten-
ive chromatographic separation of analytes is not necessary
or the selected reaction monitoring (SRM) analysis, since there
s usually only a single peak for all the analytes in an entire
hromatographic run. However, with low molecular-weight com-
ounds such as polyamines, there is an increased probability of
bserving multiple peaks from endogenous compounds in the
omplex biological samples sharing the same SRM transitions. Nev-
rtheless, we observed no multiple peaks with the same SRM
ransitions.
.4. Method validation
The present method was fully validated with human serum sam-
les to demonstrate the speciﬁcity, linearity, accuracy, precision,
ecovery, and stability of the method. A detailed summary of vali-
ation data is shown in Supplementary Tables 2S–7S.
In general, we recommend isotopically labeled internal stan-
ards for each polyamine. Isotopically labeled internal standards
fﬁciently compensate for ion suppression effects, which can be
bserved especially if samples show large variations in orn con-
entration. However, as shown in the extensive method validation,
ery good results can also be obtained by using non isotopi-
ally labeled standards within the physiological concentration
ange.
Brieﬂy, the speciﬁcity of the method was evaluated by analyz-
ng aqueous samples to investigate the potential interferences with
he analytes and internal standards in the LC peak region using
he proposed extraction, derivatization procedure and LC/MS/MS
onditions. No interfering peaks were detected. Linearity was gen-
rated by plotting the measurement signal (peak/area ratio of
nalyte/internal standard) versus nominal concentration by 1/x
eighted least squares linear regression. Evaluation of intra-day
nd inter-day accuracy and precision was performed with three
C levels. QC samples were assayed in sets of four replicates
n the same day to evaluate intra-day accuracy and precision.
nter-day accuracy and precision were carried out in eight repli-
ates on three consecutive validation days. LLoQ and LOD were
etermined for put and spd in serum samples for which the ana-
ytes had signal-to-noise-ratios of >10 and >3, respectively. For
ll other analytes, the lowest calibration concentration (1 ng/ml)
as used as LLoQ. For orn, a higher calibration range was used,
ince its concentration in serum is much higher than for otherFig. 3. LC/MS/MS chromatograms for eight polyamines in positive ESI.
polyamines. However, a lower calibration range was also tested
for orn, which revealed that the LLoQ for orn was 5 ng/ml (data
not shown). The recovery was  evaluated for put and spd spiked in
serum matrix at three QC levels. The recovery was calculated as
Cobs/Cref, where Cobs is the response of the analyte blank serum
sample subtracted from the response of spiked serum sample,
and Cref is the theoretically spiked standard concentration. Eval-
uation of the matrix effect in serum was  investigated by using
the standard addition method for put and spd. The slopes of
the external calibration plot and that obtained by the standard
addition method were compared. If the slopes have the same
gradient, no matrix effect is observable. Stability tests of the
analytes put and spd were assessed by using four replicates of
spiked serum samples at 50 g/ml under different conditions:
Serum samples and extracted serum samples were measured after
three freeze–thaw cycles (approx. 25 to −80 ◦C); short-term sta-
bility was  assessed by measuring extracted serum samples left at
2–8 ◦C for one day and long-term stability by measuring serum
samples and extracted serum samples left at −80 ◦C after 53
days.
50 C. Magnes et al. / J. Chromatog
Table  2
Anthropometric data of male and female obese patients: mean of age and
BMI  ± standard deviation.
Male Female
(n = 38) (n = 64)
Age (years) 47 ± 11 43 ± 10
BMI  (kg/m2) 46 ± 6 45 ± 7
Table 3
Mean concentration of six polyamines ± standard deviation in human serum from
male and female obese patients.
Polyamines Concentration (mean ± SD) (ng/ml)
Female N (female) Male N (male)
1-3-Diaminopropane 2.1 ± 0.9 31 2.3 ± 1 22
l-Ornithine 9 × 103
± 3 × 103
64 9.8 × 103
± 2.5 × 103
38
N-Act-putrescine 12 ± 4 64 13 ± 4 38
Putrescine 20 ± 6 64 21 ± 7 38
Spermidine 14 ± 10 64 13 ± 5 38
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 = number of patients where polyamines were detected.
.5. Quantiﬁcation of polyamines in clinical studies and samples
ith relevance for basic and biomedical research
We  applied our SPE–LC/MS/MS approach to the analysis of gen-
er differences in polyamine levels in human serum samples by
nalyzing serum samples of 102 obese patients from a clinical
tudy, of whom 38 were male (age 47 ± 11 with a body mass index
BMI) 45 ± 5) and 64 were female (age 42 ± 10 with a BMI  of 44 ± 7)
Table 2 and Supplementary Fig. 2S). The polyamine levels detected
n serum samples are shown in Table 3 and Supplementary Fig.
S. Brieﬂy, 1,3-dap could be detected in approximately half of the
emale and male patients’ serum samples. The polyamines orn, N-
ctput, put, spd and sp were detected in nearly all serum probes
nalyzed (detailed information is given in Table 3). Statistical analy-
es were performed by using the freely available statistical software
ackage R (vs. 2.15.1), which revealed no signiﬁcant differences in
olyamine concentrations between male and female obese patients
linear modeling & t-tests, p-values >0.1).
Our SPE–LC/MS/MS method has been already applied for the
ssessment of a wide variety of highly relevant samples for basic
nd biomedical research (including samples from model organisms,
ice, or human tissues) [43]. The concentrations of put, spd, sp and
rn detected in various biological samples are shown in Table 1.
his information provides us an overview of polyamine levels in
ifferent organisms ranging from yeast to worms, fruit ﬂies and
ice. Therefore our SPE–LC/MS/MS-based method is a valuable
ool for analyzing polyamine concentrations in samples of diverse
rigins, and should be especially useful for selecting suitable sam-
le/extraction volume ratios for MS  analysis.
. Conclusion
We  have described a fully validated online SPE–LC/MS/MS
ethod that allows high-throughput, rapid, and robust simulta-
eous determination of various polyamines. This is the ﬁrst report
f the use of two SPE cartridges online-coupled to LC/MS/MS for
he determination of polyamines in biological samples. Because
he SPE is online-coupled to the LC/MS/MS, the procedures, sample
reparation, chromatographic separation and measurement can
e performed in parallel, making sample measurement extremely
ast (<4 min). Furthermore, the online SPE sample preparation
lso reduces the polar and nonpolar contamination, while the
ombination of positive ESI and selective MRM  scanning allows
[
[r. A 1331 (2014) 44– 51
polyamines to be quantiﬁed under robust and sensitive conditions.
The broad dynamic range of the method allows the unambiguous
determination of eight polyamines, including 1,3-diaminopropane,
putrescine, cadaverine, N-acetyl-putrescine, spermidine, sperm-
ine, N1-acetyl-spermine, and l-ornithine, although this could be
easily extended to an even greater range. Our method is a valu-
able tool for analyzing polyamine concentration of samples of
diverse origins, including samples from model organisms, mice, or
human tissue, as well as for routine clinical analysis, as demon-
strated here: we  investigated polyamine levels in human serum
samples of obese patients, and found no signiﬁcant differences
in polyamine concentration between male and female obese
patients.
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